On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now


SenesTech Inc. (NASDAQ: SNES) Scores Major Client with Evolve(TM) Deployment in the U.S. Virgin Islands

  • SenesTech, a rodent fertility control product provider, has announced the deployment of its already successful Evolve(TM) product to the U.S. Virgin Islands
  • The Wild Ecology Group will administer the initiative and will see a rollout on over 60 islands under the group’s care
  • The deal signifies an opportunity for additional growth for the company, on the heels of an already highly successful rollout in the U.S.

SenesTech (NASDAQ: SNES), a rodent fertility control product provider and the inventor of the only EPA-registered contraceptive for male and female rats, just announced the deployment of its Evolve(TM) flagship product to the U.S. Virgin Islands in an effort administered by The Wild Ecology Group. This represents a new growth opportunity for the company, given that Wild Ecology will place regular orders as it seeks to address the growing invasive rat problem (https://ibn.fm/tqBiN).

“The Wild Ecology Group sees Evolve as part of a long term, sustainable solution to invasive species proliferation and is being rolled out to over 60 islands in our care,” noted Nick Morrison from Wild Ecology Group. “Ultimately, Evolve will be our ‘standard of care’ as we assess our programs worldwide,” he added.

“The initial multi-pallet order is already en route to the U.S. Virgin Islands, and we have reserved The Wild Ecology’s regular order in our production schedule,” noted Joel Fruendt, President and CEO of SenesTech.

The active ingredient in SenesTech’s minimum-risk soft bait for proactive control of rats has proven to effectively reduce fertility in rodents in various independent studies. This, in addition to its high palatability, easy deployment, and diverse placement in many different environments, makes it the go-to pest control product. Additionally, it presents organizations and individual consumers with a more proactive option for addressing the rodent population, as opposed to a more reactive one, as is the case with traps and poisons.

SenesTech’s management remains optimistic that 2024 will be the company’s biggest year yet, and the milestones achieved thus far point to that. They also reflect the team’s commitment to creating shareholder value and fulfilling the promises and goals set at the beginning of the year.

For more information, visit the company’s website at www.SenesTech.com.

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://ibn.fm/SNES

From Our Blog

Annovis Bio Inc. (NYSE: ANVS) Announces New Executive Team Members

July 23, 2024

Annovis Bio (NYSE: ANVS), a pioneering late-stage clinical drug platform company focusing on transformative therapies for neurodegenerative disorders such as Alzheimer’s Disease (“AD”) and Parkinson’s Disease (“PD”), is thrilled to welcome four seasoned professionals to its executive team. Maria Maccecchini, Ph.D., Founder, President, and CEO of Annovis Bio, said the company was delighted to have […]

Rotate your device 90° to view site.